The Effect of Intravesical Mitomycin C on Recurrence of Newly Diagnosed Superficial Bladder Cancer: A Further Report with 7 Years of Followup
- 1 April 1996
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 155 (4) , 1233-1238
- https://doi.org/10.1016/s0022-5347(01)66226-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis?BMJ, 1994
- The effect of intravesical thiotepa on tumour recurrence after endoscopic treatment of newly diagnosed superficial bladder cancer. A further report with long-term follow-up of a Medical Research Council randomized trialBritish Journal of Urology, 1994
- Proposal for changes in cystoscopic follow up of patients with bladder cancer and adjuvant intravesical chemotherapyBMJ, 1994
- Prognostic Factors for Recurrence and Followup Policies in the Treatment of Superficial Bladder Cancer: Report from the British Medical Research Council Subgroup On Superficial Bladder Cancer (Urological Cancer Working Party)Journal of Urology, 1989
- Using permutation tests and bootstrap confidence limits to analyze repeated events data from clinical trialsControlled Clinical Trials, 1989
- Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party)BMJ, 1988
- Prognostic Parameters in Superficial Bladder Cancer: An Analysis of 315 CasesJournal of Urology, 1982
- The Site of Recurrence of Non‐Infiltrating Bladder TumoursBritish Journal of Urology, 1978
- Single Dose Intravesical Thiotepa as an Adjuvant to Cystodiathermy in the Treatment of Transitional Cell Bladder CarcinomaBritish Journal of Urology, 1976
- SITE OF BLADDER-TUMOUR RECURRENCEThe Lancet, 1974